Stockwatch: In earnings season, the house always wins
This article was originally published in Scrip
As the third week of the full-year 2012 financial blizzard of reports brought the main part of earnings season to a stateside snowbound close, the take-home message of a difficult financial 2013 softened by spin-offs and other transactions meant that there will always be at least one winner, even if it is not an investor.
You may also be interested in...
Deals announced by Sanofi and Novartis at this year’s virtual J.P. Morgan Healthcare Conference and a smattering of full-year revenue preannouncements did not mark a bumper start to the year.
A positive start to the year for healthcare stocks was accompanied, as usual, by drug price increases. This and the other issues that have been carried over from 2020 remain just as challenging.
Agios’s divestment of its oncology pipeline and commercial operations provided a rare case where all parties appeared satisfied. In many other cases, there are winners and losers.